The two-compartment model for extravascular administration represents a drug's absorption and distribution process. It features a central compartment, where the drug is first absorbed, and a peripheral compartment, which illustrates the drug's distribution throughout the body. The rate of change in drug concentration in the central compartment is calculated by three exponents: absorption, distribution, and elimination.
The absorption exponent (ka) indicates the speed at which the drug is absorbed. The distribution exponent demonstrates how the drug is dispersed throughout the body, while the elimination exponent shows how the drug is removed from the body. These exponents can be determined using the method of residuals, provided ka is significantly larger than the distribution and elimination elements.
In addition to the method of residuals, the Loo-Riegelman method can estimate ka for drugs that follow two-compartment characteristics. This method requires data on plasma drug concentration over time after both oral and intravenous administration to the same subject at different times. Despite its intricacy, it can be applied to drugs distributed in any number of compartments. This method contrasts with the Wagner-Nelson method, typically used for drugs with one-compartment characteristics.
Two-compartment models for extravascular administration involve a central and a peripheral compartment.
For a drug entering the body via a first-order process, the equation measuring the drug concentration change over time is as follows.
This rate of change is described by three factors: the absorption, distribution, and elimination exponents.
The absorption exponent denotes how quickly the drug is absorbed, the distribution exponent describes how the drug is distributed throughout the body, and the elimination exponent accounts for how the drug is eliminated.
These terms can be resolved using the method of residuals to estimate the pharmacokinetic drug parameters.
The Loo-Riegelman method can also be used to determine ka, specifically for drugs that exhibit two-compartment characteristics.
Here, plasma drug concentration-time data is required after oral and intravenous administration of the drug to the same subject.
In contrast, the Wagner-Nelson method is typically used for drugs with one-compartment characteristics.
繁體中文
